The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation

• Published in: JIMD reports 2020-07, Vol.54 (1), p.3-8
• Main Authors: Berry, Gerard T., Blume, Elizabeth D., Wessel, Ann, Singh, Tajinder, Hecht, Leah, Marsden, Deborah, Sahai, Inderneel, Elisofon, Scott, Ferguson, Michael, Kim, Heung Bae, Harris, David J., Demirbas, Didem, Almuqbil, Mohammed, Nyhan, William L.
• Format: Article
• Language: English
• Subjects: Acidosis; Age; Amino acids; Cardiomyopathy; Case Report; Case Reports; Creatinine; Dystonia; Ejection fraction; Enzymes; Genotype & phenotype; heart failure; heart transplantation; Hypertension; Intellectual disabilities; liver transplantation; Liver transplants; Metabolism; Metabolites; Mortality; Movement disorders; organic acid disorder; Patients; Plasma; propionic acidemia; Proteins; Urine
• ISSN: 2192-8312; 2192-8304; 2192-8312
• DOI: 10.1002/jmd2.12119

Cardiomyopathy is a frequent complication of propionic acidemia (PA). It is often fatal, and its occurrence is largely independent of classic metabolic treatment modalities. Liver transplantation (LT) is a treatment option for severe PA as the liver plays a vital role in metabolism of the precursors that accumulate in patients with PA. LT in PA is now considered to be a long‐lasting and valid treatment to prevent cardiac disease. The subject of this report had severe cardiomyopathy that largely disappeared prior to undergoing a LT. Three years following the transplant, there was recurrence of cardiomyopathy following a surgery that was complicated with a postoperative aspiration pneumonia. On his last hospital admission, he was presented with pulmonary edema and heart failure. He continued with episodes of intractable hypotension, despite maximum inotropic and diuretic support. He died following redirection of care. We conclude that lethal cardiomyopathy may develop several years after successful LT in patients with PA.